Home > Healthcare > Medical Devices > Diagnostic Devices > Nuclear Imaging Devices Market

Nuclear Imaging Devices Market Size

  • Report ID: GMI5861
  • Published Date: May 2023
  • Report Format: PDF

Nuclear Imaging Devices Market Size

Nuclear Imaging Devices Market size was valued at over USD 3 billion in 2022 and is anticipated to grow at a CAGR of over 4.9% between 2023 and 2032.  Growing demand for non-invasive diagnostic tools along with rising emphasis on personalized medicine, thereby impelling the demand for nuclear imaging devices industry.

 

The industry refers to the segment of the medical imaging industry that involves the use of radioactive tracers and specialized imaging equipment to visualize and assess the physiological and metabolic functions of organs and tissues within the human body. Nuclear imaging techniques utilize radiopharmaceuticals that emit gamma rays or positrons, which are detected by dedicated imaging devices to create images and provide functional information. The market is driven by several factors such as the increasing prevalence of chronic diseases, technological advancements in imaging systems and radiopharmaceuticals.

 

Rapid technological advancements in nuclear imaging offering better imaging capabilities, improve patient outcomes will drive overall growth of the industry. Also, emergence of hybrid imaging systems with combination of the functional imaging capabilities of nuclear imaging modalities like SPECT and PET with anatomical imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI). Hybrid systems, such as PET/CT and SPECT/CT provide comprehensive and precise imaging by merging functional and structural information and allows improved diagnostic accuracy, better localization of abnormalities and enhanced patient management. In addition, several market players are emphasizing on research and development activities for the development of novel nuclear imaging devices will accelerate industry expansion.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market size for nuclear imaging devices was valued at over USD 3 billion in 2022 and is projected to reach more than USD 5 billion by 2032, owing to increasing prevalence of chronic diseases, technological advancements in imaging systems and radiopharmaceuticals, growing demand for non-invasive diagnostic tools, and rising emphasis on personalized medicine.

Oncology segment accounted for more than 49% market share in the year 2022. Increasing usage of positron emission tomography imaging for diagnosis, treatment planning, and response assessment of various cancers will contribute to nuclear imaging devices industry size.

U.S. nuclear imaging devices market accounted for more than USD 950 million in 2022 and will garner over USD 1,505 million by 2032, on account of wider integration of remote monitoring as well as adoption of telehealth solutions, along with high spending on healthcare management.

DSurgicEye GmbH, CMR Naviscan., Absolute Imaging Inc., Bartec Technologies Ltd., BCL X-Ray Canada Inc., TTG Imaging Solutions, LLC., Lucerno Dynamics, LLC., Berthold Technologies GmbH & Co.KG, Incom Inc., Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers AG among others.

Nuclear Imaging Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 280
  • Countries covered: 30
  • Pages: 183
 Download Free Sample